Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Dermatologic 3

Conditions

Hodgkin Disease 9Lymphoma 8Lymphoma, T-Cell, Cutaneous 4Mycosis Fungoides 3Recurrence 1Lymphomatoid Papulosis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Disease 1Dermatitis, Contact 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 39fludarabine phosphate 37Cyclophosphamide 33Mycophenolic Acid 28Whole-Body Irradiation 24Cyclosporine 24Tacrolimus 22Radiotherapy 19Methotrexate 18Busulfan 18Antilymphocyte Serum 17Flow Cytometry 14Filgrastim 14Etoposide 14Vorinostat 11Bortezomib 11Bexarotene 11mogamulizumab 10Methylprednisolone 10Lenalidomide 10pembrolizumab 9Rituximab 9Melphalan 9Gemcitabine 9Brentuximab Vedotin 9romidepsin 8Therapeutics 8Psychiatric Rehabilitation 8Polymerase Chain Reaction 8Methoxsalen 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Mycosis Fungoides × Mechlorethamine × Clear all
NCT05303480 2023-01-25

Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides

Centre for Human Drug Research, Netherlands

Phase NA Completed
32 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT03380026 2021-11-24

MIDAS

Rochester Skin Lymphoma Medical Group, PLLC

Phase 2 Completed
28 enrolled 8 charts
DermatologicLymphoid

Dermatitis, Contact, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT00168064 2012-10-31

Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides

Yaupon Therapeutics

Phase 2 Completed
260 enrolled 8 charts
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡